The association between body composition and overall survival in patients with advanced non-small cell lung cancer

被引:0
|
作者
Fu, Liang [1 ]
Ding, Haiming [1 ]
Mo, Liupei [1 ]
Pan, Xiaoyu [1 ]
Feng, Lijuan [1 ]
Wen, Shenglian [1 ]
Lan, Qiaoqing [1 ]
Long, Liling [1 ,2 ]
机构
[1] Guangxi Med Univ, Dept Radiol, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China
[2] Gaungxi Med Univ, Key Lab Early Prevent & Treatment Reg High Frequen, Minist Educ, Nanning, Peoples R China
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
NSCLC; Body composition; Skeletal muscle; Subcutaneous fat; Overall Survival; ADIPOSE-TISSUE; OBESITY; OUTCOMES; TUMORS; CLASSIFICATION; RADIODENSITY; INFLAMMATION; DEPLETION; IMPACT;
D O I
10.1038/s41598-025-87073-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nutritional status is associated with prognosis in a variety of cancers. Studies analyzing the association between the measurements of skeletal muscle and adipose tissue obtained from Computerized Tomography (CT) images at the time of diagnosis of advanced non-small cell lung cancer (NSCLC) and overall survival (OS) are relatively few. Data from 425 patients diagnosed with advanced NSCLC between January 2016 and December 2017 were retrospectively analyzed, with an average follow-up of 15.3 months. To outline the patient's chest CT plain image at the time of diagnosis,skeletal muscle and subcutaneous fat at the level of both thoracic vertebrae were quantified in terms of mass and quantity by the pectoral muscle index (PMI), pectoral muscle density (PMD), subcutaneous fat index (SFI), subcutaneous fat density (SFD), paravertebral muscle index (PVMI), and paravertebral muscle density (PVMD). The SFI value in the female survival group is significantly lower than that in the death group (P = 0.049), and the PVMI value in the overall survival group is significantly lower than that in the death group (P < 0.001). After adjusting for clinical variables such as gender, smoking status, clinical staging, degree of differentiation, and radiotherapy history, the multivariable Cox regression analysis showed that an increase in SFI significantly improves the overall survival rate of patients (Hazard Ratio [HR] = 1.410, 95% Confidence Interval [CI]: 1.042-1.908, P = 0.026). Conversely, a decrease in PVMD is significantly associated with improved overall survival and prognosis (HR = 0.762, 95% CI: 0.579-0.982, P = 0.048). No association was found between body mass index (BMI) and chest muscle status indicators and overall survival (P > 0.05). CT-measured body composition parameters provide precise prognostic information and are superior to BMI; an increased OS rate in advanced NSCLC is associated with a greater SFI and a lower PVMD.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Genome-Wide Association Study on Overall Survival of Advanced Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel
    Sato, Yasunori
    Yamamoto, Noboru
    Kunitoh, Hideo
    Ohe, Yuichiro
    Minami, Hironobu
    Laird, Nan M.
    Katori, Noriko
    Saito, Yoshiro
    Ohnami, Sumiko
    Sakamoto, Hiromi
    Sawada, Jun-ichi
    Saijo, Nagahiro
    Yoshida, Teruhiko
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 132 - 138
  • [22] Association Between Body Mass Index and Survival in Patients with De Novo Metastatic Non-Small Cell Lung Cancer
    Urun, Muslih
    Guner, Gurkan
    Sezgin, Yasin
    Sakin, Abdullah
    Kilickap, Saadettin
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [23] Early Changes in Body Composition in Metastatic Non-Small Cell Lung Cancer (NSCLC) Are Predictive for Poor Overall Survival
    Degens, J.
    Sanders, K.
    De Jong, E.
    Schols, A.
    Dingemans, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2086 - S2087
  • [24] Association between baseline tumor dimensions and survival in advanced non-small cell lung cancer (NSCLC)
    Ahn, Daniel H.
    Dahlberg, Suzanne Eleanor
    Sandler, Alan
    Perry, Michael C.
    Schiller, Joan H.
    Brahmer, Julie R.
    Johnson, David H.
    Gerber, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival
    Afanasjeva, Janna
    Hui, Rita L.
    Spence, Michele M.
    Chang, Jennifer
    Schottinger, Joanne E.
    Millares, Mirta
    Rashid, Nazia
    PHARMACOTHERAPY, 2016, 36 (10): : 1065 - 1074
  • [26] Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
    Pan, Mingmei
    Zhao, Yun
    He, Jianbo
    Wu, Huanqiong
    Pan, Yujia
    Yu, Qitao
    Zhou, Shaozhang
    JOURNAL OF CANCER, 2021, 12 (08): : 2395 - 2402
  • [27] Prognostic Factors for Overall Survival among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Verleger, Katharina
    Treur, Maarten
    Penrod, John
    Daumont, Melinda
    Lees, Michael
    Macahilig, Cynthia
    Solem, Caitlyn
    Jiang, Shan
    Chirita, Oana
    Hertel, Nadine
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S995 - S996
  • [28] Biomarker Testing and Overall Survival among Patients Diagnosed with Advanced or Metastatic Non-small Cell Lung Cancer
    Hess, L.
    Beyrer, J.
    Abedtash, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S79 - S79
  • [29] Symptom Trajectories During Chemotherapy Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer
    Shi, Q.
    Wang, X.
    Williams, L.
    Mendoza, T.
    Simon, G.
    Cleeland, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2082 - S2082
  • [30] BASELINE POPULATION CHARACTERISTICS AND THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS
    Kulakova, M.
    Hashim, M.
    Pfeiffer, B.
    Postma, M.
    Heeg, B.
    VALUE IN HEALTH, 2017, 20 (09) : A420 - A421